Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.

Clinical and molecular hepatology - 1 Sept 2016

Kim Jong Man, Lee Kwang-Woong, Song Gi-Won, Jung Bo-Hyun, Lee Hae Won, Yi Nam-Joon, Kwon ChoonHyuck David, Hwang Shin, Suh Kyung-Suk, Joh Jae-Won, Lee Suk-Koo, Lee Sung-Gyu

Abstract excerpt

BACKGROUND/AIMS: The relationship between patient survival and biopsy-proven acute rejection (BPAR) in liver transplant recipients with hepatitis C remains unclear. The aims of this study were to compare the characteristics of patients with and without BPAR and to identify risk factors for BPAR. METHODS: We retrospectively reviewed the records of 169 HCV-RNA-positive patients who underwent LT at three centers....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclosporine
Share to Drug Therapy, Combination

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Graft Rejection

Share to Hepatitis C

Share to Immunosuppressive Agents

Share to Liver Transplantation

Share to Recurrence

Share to Tacrolimus

Source

Open in PubMed Open full text

Identifiers

PMID: 27729628
DOI: 10.3350/cmh.2016.0022
PMCID: PMC5066384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection.PMID 27729628Read ↗

Molecular signatures discriminating different types of rejection in human liver transplantsSemantic proximity Read ↗

The effect of pretransplant chronic hepatitis C virus infection treatment on graft and patient survival in renal transplant recipients.Semantic proximity Read ↗

Molecular signatures of chronic antibody-mediated rejection in human liver transplantsSemantic proximity Read ↗

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.Semantic proximity Read ↗

Graft Versus Host Disease After Liver Transplantation in AdultsSemantic proximity Read ↗

ABO-compatible liver allograft antibody-mediated rejection: an update.Semantic proximity Read ↗

Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used.Semantic proximity Read ↗

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.Semantic proximity Read ↗

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation.Semantic proximity Read ↗

Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft Survival.Semantic proximity Read ↗

Curing hepatitis C virus (HCV) after organ transplantation: Increased risk of rejection following HCV elimination.Semantic proximity Read ↗

Long-term outcome of hepatitis C virus infection after liver transplantation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.